Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug

Arrowhead’s RNA drugs could aid with “high-quality” weight loss, according to one analyst. Elsewhere, the PD-1/VEGF field got less crowded and Amgen and Lilly struck startup deals.

Experts ousted from CDC panel warn of damage to US vaccine policy

15 states sue HHS over changes to childhood vaccine schedule

February 25, 2026

Failure of REA boss to appear before Reps described as ‘disrespectful’ – EnviroNews

February 25, 2026

Source link

Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug

15 states sue HHS over changes to childhood vaccine schedule

Failure of REA boss to appear before Reps described as ‘disrespectful’ – EnviroNews

Billions of Miles Later, We Now Know if Autonomous Cars Can Be Trusted

As Army narrows field for its flight-school outsourcing contract, Congress says: not so fast

As Army narrows field for its flight-school outsourcing contract, Congress says: not so fast

Leave a Reply Cancel reply

RECOMMENDED NEWS

Hundreds of Kenyans Facing Deportation

Navigating The Current Trends In South Africa’s Construction Sector

Rapid Deployment Brigade to the fore at Exercise Vuk’uhlome 2025

American Museum of Natural History has repatriated more than 100 Native American human remains and 90 objects

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug

Related posts

Billions of Miles Later, We Now Know if Autonomous Cars Can Be Trusted

As Army narrows field for its flight-school outsourcing contract, Congress says: not so fast

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS